Conformis and Stryker Settle Patent Dispute

In April of 2020, Conformis filed a lawsuit against Wright Medical, which was acquired by Stryker for $4 billion.

Omar Ford

July 7, 2021

1 Min Read
IMG_Jul72021at14231PM.jpg
Scott Maxwell - stock.adobe.com

Conformis said it has entered into a settlement agreement with Stryker regarding a patent dispute. The settlement calls for Stryker to make a one-time payment to the Billerica, MA-based company and be granted a non-exclusive license with respect to certain Conformis patents.

In April of 2020, Conformis filed a lawsuit against Wright Medical, which was acquired by Stryker for $4 billion. Conformis’s amended complaint alleged that Wright Medical’s multiple lines of patient-specific shoulder instruments, as well as the implant components used in conjunction with them, infringed certain Conformis patents.

“We are pleased to have resolved all of the ongoing patent litigation related to the Wright Medical dispute,” said Mark Augusti, Conformis’s president and CEO. “The settlement once again highlights the strength and value of our intellectual property, as well as our steadfast commitment to protecting and enforcing it.”

The settlement comes as Conformis is making a significant strategic shift to standard knee implants. For years the company was known for its higher-cost customized knee implants.

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like